...
机译:C-X-C趋化因子受体2(CXCR2)通过调节程序死亡 - 配体1(PD-L1)促进肝细胞癌免疫逃离
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
Zhejiang Univ Hangzhou Peoples Hosp 1 Dept Hepatopancreatobiliary Surg Affiliated Hosp Med Sch;
c-Myc; CXCL8; Cxcr2; hepatocellular carcinoma; immune escape; PD-L1;
机译:C-X-C趋化因子配体12 / C-X-C趋化因子受体4在肝细胞癌进展中的作用
机译:趋化因子(C-X-C主题)配体13促进原发性胆汁性肝硬化中肝内趋化因子(C-X-C主题)受体5+淋巴细胞归巢和异常B细胞免疫反应
机译:77.编程死亡 - 配体1(PD-L1)之间的关联(PD-L1)表达和基因签名对肝细胞癌(HCC)的Tislelizumab单药治疗
机译:雌激素受体α多态性与肝炎病毒携带者的肝细胞癌敏感相关
机译:疱疹病毒编码的趋化因子诱饵受体的生物物理研究阐明了病毒逃避免疫的原理。
机译:C-X-C趋化因子配体12 / C-X-C趋化因子受体4在肝细胞癌进展中的作用
机译:C-X-C趋化因子配体12 / C-X-C趋化因子受体4在肝细胞癌进展中的作用